MC10 Inc, developer of the BioStampRC wearable sensor system, and the Shirley Ryan AbilityLab announce a research collaboration investigating how the BioStampRC system can be used to help advance the rehabilitation process.
“MC10’s technology has the potential to reshape rehabilitation. We look forward to developing new therapies and solutions with BioStampRC sensors, furthering our goal of improving treatment and recovery, and of advancing human ability,” states David Zembower, PhD, executive director of innovation and clinical research at the Shirley Ryan AbilityLab, in a media release.
Research performed by MC10 Inc and Shirley Ryan AbilityLab will focus on identifying unmet clinical and therapeutic needs in the physical medicine and rehabilitation field. Initial target areas will include injuries that result in motion/biomechanics-related disabilities, especially stroke, traumatic brain injury, incomplete spinal cord injury, and various neurodegenerative diseases.
“MC10 is dedicated to improving healthcare with digital solutions. By collaborating with the Shirley Ryan AbilityLab, an institution committed to driving breakthroughs in human ability, we’re positioning our technology to make a real, positive impact in human health,” MC 10 CEO Scott Pomerantz comments, in the release.
[Source(s): MC 10 Inc, Shirley Ryan AbilityLab, Business Wire]
